New eye drops aim to soothe dry eye sufferers

NCT ID NCT07179055

Recruiting now Symptom relief Sponsor: Vanda Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a new eye drop called VSJ-110 can safely ease dry eye symptoms. About 160 adults will use either the active drops or a placebo for eight weeks. Researchers will check for changes in eye surface damage, tear production, and discomfort.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: VSJ-110 ophthalmic solution (eye drops)
What this could lead to: If successful, this could lead to a new prescription eye drop that reduces eye damage and discomfort for people with dry eye.
What could go wrong: This is an early Phase 2 trial with only 160 people. The drug may not work better than placebo, and side effects are still being studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY EYE

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Vanda Investigational Site
RECRUITING

Newport Beach, California, 92663, United States
Vanda Investigational Site
NOT_YET_RECRUITING

Andover, Massachusetts, 01810, United States
Vanda Investigational Site
NOT_YET_RECRUITING

Shelby, North Carolina, 28150, United States
Vanda Investigational Site
RECRUITING

Memphis, Tennessee, 38119, United States
Vanda Investigational Site
NOT_YET_RECRUITING

Lynchburg, Virginia, 24502, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.